DexCom Inc.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|---|
| Revenue | $48.0M | $29.7M | $9.7M | $4.6M | $2.0M |
| United States | $47.1M | — | $9.7M | $4.6M | $2.0M |
| International | $872.0K | — | $0 | $0 | $0 |
| Cost of Revenue | $30.2M | $26.0M | — | — | — |
| Gross Profit | $18.4M | $3.7M | — | — | — |
| Gross Margin | 38.4% | 12.3% | — | — | — |
| Operating Expenses | |||||
| Research & Development | $23.2M | $14.3M | — | — | — |
| SG&A Expense | $40.5M | $35.2M | — | — | — |
| Operating Income | $-45.3M | $-45.8M | — | — | — |
| Operating Margin | -94.5% | -154.4% | — | — | — |
| Interest Expense | $1.5M | $8.0M | — | — | — |
| Pretax Income | $-55.2M | — | — | — | — |
| Income Tax Expense | $0 | — | — | — | — |
| Net Income | $-55.2M | $-53.5M | — | — | — |
| Net Margin | -115.1% | -180.3% | — | — | — |
| EPS (Basic) | $-0.19 | $-0.24 | — | — | — |
| EPS (Diluted) | $-0.19 | $-0.24 | — | — | — |
| Shares Outstanding (Basic) | 310.4M | — | — | — | — |
| Shares Outstanding (Diluted) | 310.4M | — | — | — | — |
| Dividends Per Share | — | — | — | — | — |